Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients

British Journal of Cancer

Volumn 94, Issue 7, 2006, Pages 1057-1065

  Innes, H E ^a   Liu, D ^b   Barraclough, R ^b   Davies, M P A ^a   O'Neill, P A ^a   Platt Higgins, A ^b   De Silva Rudland, S ^b   Sibson, D R ^a   Rudland, P S ^b  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

AGR2 immunocytochemistry; ER positive breast cancer; Patient survival

Indexed keywords

ANTERIOR GRADIENT PROTEIN 2; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CARCINOMA CELL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FISHER EXACT TEST; FOLLOW UP; HAZARD ASSESSMENT; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LINEAR REGRESSION ANALYSIS; LOG RANK TEST; MAJOR CLINICAL STUDY; METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEINS; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33645751864     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603065     Document Type: Article

References (24)

1. Altman DG (1991) Practical Statistics for Medical Research. London: Chapman and Hall
2. Anandappa SY, Winstanley JH, Leinster S, Green B, Rudland PS, Barraclough R (1994) Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer 69: 772-776
3. Clarke R, Dickson RB, Brümer N (1990) The process of malignant progression in human breast cancer. Ann Oncol 1: 401-407
4. Clarke R, Thompson EW, Leonessa F, Lippman J, McGarvey M, Frandsen TL, Brünner N (1994) Hormone resistance, invasiveness and metastatic potential in breast cancer. Br Cancer Res Treat 24: 227-239
5. Davies BR, Davies MP, Gibbs FE, Barraclough R, Rudland PS (1993) Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 8: 999-1008
6. de Silva Rudland S, Martin L, Roshanlall C, Winstanley J, Leinster S, Platt-Higgins A, Carroll J, West C, Barraclough R, Rudland PS (2006) Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res 12: 1192-1200
7. Early Breast Cancer Trialists' Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687-1717
8. El-Tanani M, Fernig DG, Barraclough R, Green C, Rudland PS (2001) Differential modulation of transcriptional activity of estrogen receptors by direct protein - protein interactions with the Tcf family of transcription factors. J Biol Chem 276: 41675-41682
9. Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, Terrett JA (2003) hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer 88: 579-585
10. Kamby C (1990) The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors. Cancer Treat Rev 17: 37-61
11. Kern FG, McLeskey SW, Zhang L, Kurebayashi J, Liu Y, Ding IYF, Kharbanda S, Chen D, Miller D, Cullen K, Paik S, Dickson RB (1994) Transfected MCF-7 cells as a model for breast cancer progression. Br Cancer Res Treat 31: 153-165
12. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R (2005) Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res 65: 3796-3805
13. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408
14. Martin L, Green B, Renshaw C, Lowe D, Rudland P, Leinster SJ, Winstanley J (1997) Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer 76: 1046-1054
15. Moye VE, Barraclough R, West C, Rudland PS (2004) Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing rat mammary cell lines. Br J Cancer 90: 1796-1802
16. Oates AJ, Barraclough R, Rudland PS (1996) The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13: 97-104
17. O'Neill PA, Davies MP, Shaaban AM, Innes H, Torevell A, Sibson DR, Foster CS (2004) Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in tamoxifen-treated post-menopausal breast cancers. Br J Cancer 91: 1694-1702
18. Platt-Higgins AM, Renshaw CA, West CR, Winstanley JH, de Silva Rudland S, Barraclough R, Rudland PS (2000) Comparison of the metastasis-inducing protein S100A4 (p9Ka) with other prognostic markers in human breast cancer. Int J Cancer 89: 198-208
19. Rudland PS, Dunnington DJ, Kim U, Gusterson BA, O'Hare MJ, Monaghan P (1989) Isolation and properties of cell lines from the metastasising rat mammary tumour SMT-2A. Br J Cancer 59: 1854-1864
20. Rudland PS, Platt-Higgins A, El-Tanani M, de Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR (2002) Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 62: 3417-3427
21. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L, Barraclough R (2000) Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603
22. Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14: 2738-2746
23. Soule HD, Vazquez A, Long A, Albert S, Brennan MA (1973) Human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1413
24. Thompson DA, Weigel RJ (1998) hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem Biophys Res Commun 251: 111-116